These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17216876)

  • 1. Intracranial hemorrhage with Aptivu.
    AIDS Patient Care STDS; 2006 Dec; 20(12):889. PubMed ID: 17216876
    [No Abstract]   [Full Text] [Related]  

  • 2. New black box warning for ritonavir-boosted tipranavir.
    Ryan CT
    AIDS Clin Care; 2006 Aug; 18(8):72. PubMed ID: 16906669
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracranial hemorrhage and liver-associated deaths associated with tipranavir/ritonavir: review of cases from the FDA's Adverse Event Reporting System.
    Chan-Tack KM; Struble KA; Birnkrant DB
    AIDS Patient Care STDS; 2008 Nov; 22(11):843-50. PubMed ID: 19025478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptivus in the hotseat. Excerpts from the FDA hearings.
    Huff B
    GMHC Treat Issues; 2005; 19(5-6):6-8. PubMed ID: 16193577
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute pancreatitis caused by tipranavir/ritonavir-induced hypertriglyceridaemia.
    Chapman SJ; Woolley IJ; Visvanathan K; Korman TM
    AIDS; 2007 Feb; 21(4):532-3. PubMed ID: 17301578
    [No Abstract]   [Full Text] [Related]  

  • 6. Porphyria cutanea tarda in an HIV-1-infected patient after the initiation of tipranavir/ritonavir: case report.
    Celesia BM; Onorante A; Nunnari G; Mughini MT; Mavilla S; Massimino SD; Russo R
    AIDS; 2007 Jul; 21(11):1495-6. PubMed ID: 17589203
    [No Abstract]   [Full Text] [Related]  

  • 7. Boehringer drug for resistant HIV approved.
    AIDS Read; 2005 Aug; 15(8):379, 391. PubMed ID: 16110551
    [No Abstract]   [Full Text] [Related]  

  • 8. New protease inhibitor offers clinicians hope for better salvage therapy.
    Murphy MJ
    HIV Clin; 2006; 18(1):1-3. PubMed ID: 16838417
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracranial haemorrhage possibly related to Tipranavir in an HIV-1 patient with cryptococcal meningitis.
    Chrysos G; Gerakari S; Stasini F; Kokkoris S; Kourousis D; Velegraki A
    J Infect; 2008 Jul; 57(1):85-7. PubMed ID: 18314196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA approval: tipranavir.
    Sax PE
    AIDS Clin Care; 2005 Aug; 17(8):78. PubMed ID: 16193574
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves tipranavir.
    IAPAC Mon; 2005 Jul; 11(7):190. PubMed ID: 16676422
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe hepatotoxicity associated with the combination of enfuvirtide and tipranavir/ritonavir: case report.
    Jülg B; Bogner JR; Goebel FD
    AIDS; 2006 Jul; 20(11):1563. PubMed ID: 16847416
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased risk of bleeding with the use of tipranavir boosted with ritonavir in haemophilic patients.
    Arbuthnot C; Wilde JT
    Haemophilia; 2008 Jan; 14(1):140-1. PubMed ID: 18184260
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?
    Justice AC; Zingmond DS; Gordon KS; Fultz SL; Goulet JL; King JT; Bravata DM; Valdez H; Kraft M; Mattocks KM;
    Clin Infect Dis; 2008 Nov; 47(9):1226-30. PubMed ID: 18831696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA approves Aptivus (tipranavir).
    Pham PA
    Hopkins HIV Rep; 2005 Jul; 17(4):6-7. PubMed ID: 16419308
    [No Abstract]   [Full Text] [Related]  

  • 16. Aptivus capsules granted full FDA approval.
    AIDS Patient Care STDS; 2007 Nov; 21(11):889-90. PubMed ID: 18338430
    [No Abstract]   [Full Text] [Related]  

  • 17. Tipranavir (Aptivus) for HIV.
    Med Lett Drugs Ther; 2005 Oct; 47(1219):83-4. PubMed ID: 16247341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV agents. Tipranavir in treatment-experienced PHAs.
    TreatmentUpdate; 2005; 17(1):4-5. PubMed ID: 17225315
    [No Abstract]   [Full Text] [Related]  

  • 19. Tipranavir: new drug. HIV protease inhibitor. A last resort.
    Prescrire Int; 2006 Dec; 15(86):217-9. PubMed ID: 17167925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA notifications. Norvir label changes approved.
    AIDS Alert; 2008 Oct; 23(10):115-6. PubMed ID: 18938256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.